Researcher profile

Eric O. Aboagye

Eric O. Aboagye contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

Fully-automated deep learning slice-based muscle estimation from CT images for sarcopenia assessment

Objective: To demonstrate the effectiveness of using a deep learning-based approach for a fully automated slice-based measurement of muscle mass for assessing sarcopenia on CT scans of the abdomen without any case exclusion criteria. Materials and Methods: This retrospective study was conducted using a collection of public and privately available CT images (n = 1070). The method consisted of two stages: slice detection from a CT volume and single-slice CT segmentation. Both stages used Fully Convolutional Neural Networks (FCNN) and were based on a UNet-like architecture. Input data consisted of CT volumes with a variety of fields of view. The output consisted of a segmented muscle mass on a CT slice at the level of L3 vertebra. The muscle mass is segmented into erector spinae, psoas, and rectus abdominus muscle groups. The output was tested against manual ground-truth segmentation by an expert annotator. Results: 3-fold cross validation was used to evaluate the proposed method. The slice detection cross validation error was 1.41+-5.02 (in slices). The segmentation cross validation Dice overlaps were 0.97+-0.02, 0.95+-0.04, 0.94+-0.04 for erector spinae, psoas, and rectus abdominus, respectively, and 0.96+-0.02 for the combined muscle mass. Conclusion: A deep learning approach to detect CT slices and segment muscle mass to perform slice-based analysis of sarcopenia is an effective and promising approach. The use of FCNN to accurately and efficiently detect a slice in CT volumes with a variety of fields of view, occlusions, and slice thicknesses was demonstrated.

preprint2020arXiv

Label-Free Chemical Nano-Imaging of Intracellular Drug Binding Sites

Optical microscopy has a diffraction limited resolution of about 250 nm. Fluorescence methods (e.g. PALM, STORM, STED) beat this, but they are still limited to 10 s of nm, and the images are an indirect pointillist representation of only part of the original object. Here we describe a way of combining a sample preparation technique taken from histopathology, with a probe-based nano-imaging technique, (s SNOM) from the world of Solid State Physics. This allows us to image subcellular structures optically, and at a nanoscale resolution that is about 100 x better than normal microscopes. By adding a tuneable laser source, we also demonstrate mid-infrared chemical nano-imaging (MICHNI) in human myeloma cells and we use it to map the binding sites of the anti cancer drug bortezomib to less than 10 zL sized intracellular components. MICHNI is label free and can be used with any biological material and drugs with specific functional chemistry. We believe that its combination of speed, cheapness, simplicity, safety and chemical contrast promises a transformative impact across the life sciences.